A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study.
Saved in:
| Title: | A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study. |
|---|---|
| Authors: | Eriksen, Martina1,2 (AUTHOR) martina.amnitzboell.eriksen@regionh.dk, Pfeiffer, Per3 (AUTHOR), Rohrberg, Kristoffer Staal1 (AUTHOR), Yde, Christina Westmose4 (AUTHOR), Petersen, Lone Nørgård1 (AUTHOR), Poulsen, Laurids Østergaard5 (AUTHOR), Qvortrup, Camilla1,2 (AUTHOR) |
| Source: | BMC Cancer. 12/19/2022, Vol. 22 Issue 1, p1-6. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 160868411 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Eriksen%2C+Martina%22">Eriksen, Martina</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> martina.amnitzboell.eriksen@regionh.dk</i><br /><searchLink fieldCode="AR" term="%22Pfeiffer%2C+Per%22">Pfeiffer, Per</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rohrberg%2C+Kristoffer+Staal%22">Rohrberg, Kristoffer Staal</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yde%2C+Christina+Westmose%22">Yde, Christina Westmose</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Petersen%2C+Lone+Nørgård%22">Petersen, Lone Nørgård</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Poulsen%2C+Laurids+Østergaard%22">Poulsen, Laurids Østergaard</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qvortrup%2C+Camilla%22">Qvortrup, Camilla</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 12/19/2022, Vol. 22 Issue 1, p1-6. 6p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160868411 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-022-10420-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 1 Titles: – TitleFull: A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Eriksen, Martina – PersonEntity: Name: NameFull: Pfeiffer, Per – PersonEntity: Name: NameFull: Rohrberg, Kristoffer Staal – PersonEntity: Name: NameFull: Yde, Christina Westmose – PersonEntity: Name: NameFull: Petersen, Lone Nørgård – PersonEntity: Name: NameFull: Poulsen, Laurids Østergaard – PersonEntity: Name: NameFull: Qvortrup, Camilla IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 12 Text: 12/19/2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |
